Get all premium features to the best stock analysis tool

Finranks

Company

About us

Contact us

[email protected]

Follow us

Instagram
Telegram
LinkedIn

All rights reserved.

Privacy Policy Terms of Conditions

Home
Markets
Screener
News
About

Home

AXON

A

Axon Enterprise, Inc. (AXON)

NMS – Real Time Price. Currency in USD

429.94

-20.52 (-4.56%)

At close: Mar 27, 2026, 4:00 PM EDT

430.00

+0.06 (0.01%)

After-hours: Mar 27, 2026, 7:54 PM EDT

Summary
News
Chart
Financial
Dividends
Forecast
Ownership
Profile

Videos

Axon CEO Rock Smith goes one-on-one with Jim Cramer

Axon CEO Rick Smith talks acquiring emergency tech firm Carbyne

Calls of the Day: Leidos, Eaton Corp, Caterpillar and Axon

Axon, maker of nonlethal tasers, aims to cut police deaths by 50%

Press releases

Axon reports Q4 2025 revenue of $797 million, up 39% year over year

Axon reports Q4 2025 revenue of $797 million, up 39% year over year

SCOTTSDALE, Ariz., Feb. 24, 2026 /PRNewswire/ -- Software & Services revenue grows 40% to $343 million Net income of $3 million supports non-GAAP net income of $178 million and Adjusted EBITDA of $206 million Company establishes 2026 outlook of 27% to 30% revenue growth and a 25.5% Adjusted EBITDA margin Introduces new 2028 targets of $6 billion in annual revenue and 28% Adjusted EBITDA margin Fellow shareholders, Axon completed another record year in pursuit of our mission to protect life.

Axon Vision Announce Strategic Cooperation Agreement with Leonardo DRS to Deliver AI-Enhanced Counter-UAS Solutions for U.S. Market

Axon Vision Announce Strategic Cooperation Agreement with Leonardo DRS to Deliver AI-Enhanced Counter-UAS Solutions for U.S. Market

TEL AVIV, Israel , Dec. 3, 2025 /PRNewswire/ -- Axon Vision (TASE: AXN) announced today a strategic cooperation agreement with Leonardo DRS to pursue opportunities in advanced situational awareness, lethality, and survivability, with special emphasis on Counter-UAS (C-UAS) solutions in the U.S. defense market. The partnership is expected to address a critical demand for on-platform AI-driven capabilities that support force protection and platform modernization.

ZAP Surgical's ZAP-Axon Radiosurgery Planning System Receives U.S. FDA 510(k) and E.U. CE Clearance

ZAP Surgical's ZAP-Axon Radiosurgery Planning System Receives U.S. FDA 510(k) and E.U. CE Clearance

SAN CARLOS, Calif.--(BUSINESS WIRE)--ZAP Surgical Systems, Inc., a pioneer in non-invasive robotic brain surgery, today announced that its award-winning ZAP-Axon® Radiosurgery Planning System has received both U.S. FDA 510(k) clearance and European CE certification. These key regulatory milestones authorize clinical use of ZAP-Axon throughout the United States and European Union, marking a significant advance in the evolution of world-class radiosurgery planning. Dedicated exclusively to crania.

Axon to Acquire Carbyne, Uniting Cloud Infrastructure and AI to Redefine the 911 Experience

Axon to Acquire Carbyne, Uniting Cloud Infrastructure and AI to Redefine the 911 Experience

Acquisition brings next-generation, cloud-native 911 technology into the Axon ecosystem, uniting connected devices, real-time communications, and digital evidence from call to courtroom. SCOTTSDALE, Ariz.